EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2025

EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2025

  • January 2017 •
  • 101 pages •
  • Report ID: 4683553 •
  • Format: PDF
EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2025

Summary

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in the lining of the digestive tract. In UC, because of an abnormal response of the body’s immune system, the lining of the colon becomes inflamed and develops tiny open sores, or ulcers, that produce pus and mucous. This causes abdominal discomfort and frequent emptying of the colon. UC is a type of IBD, not to be confused with irritable bowel syndrome (IBS), a disorder that affects the muscle contractions of the colon and is not characterized by intestinal inflammation.

UC commonly affects teenagers and young adults, and can result in poor development and growth; nonetheless, the disease can also occur in children and older individuals (CCFA, 2016a). Unlike the other form of IBD-Crohn’s disease (CD), which has similar symptoms but can occur anywhere in the digestive tract, with ulceration deep into the tissues-UC is limited to the colon and has less frequent complications, such as rupture of the colon, bleeding from deep ulcerations, and failure of treatment response.

In the 7MM, epidemiologists forecast that the diagnosed incident cases of UC will increase from 86,509 cases in 2015 to 95,864 cases in 2025, at an annual growth rate (AGR) of 1.08%. The US will have the highest number of diagnosed incident cases of UC over the forecast period, while Spain will have the lowest.
Epidemiologists forecast that the undiagnosed prevalent cases of UC will increase from 556,966 cases in 2015 to 614,036 cases in 2025, at an AGR of 1.02%. The US will have the highest number of undiagnosed prevalent cases of UC over the forecast period, while Spain will have the lowest.

The report “EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of UC in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases of UC segmented by sex and age in these seven markets. The diagnosed incident cases are further segmented by stage at diagnosis and severity grading. The diagnosed prevalent cases are further segmented by severity grading. Additionally, autoimmune comorbidities, colectomy due to failure of medical management, and mortality due to complications of UC among the diagnosed prevalent cases of UC are also included in this analysis. Furthermore, the report includes diagnosed incident cases and diagnosed prevalent cases of indeterminate colitis (IC) for both sexes and all ages in the 7MM.

Scope

- The Ulcerative Colitis (UC) EpiCast Report provides an overview of the risk factors and global trends of UC in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases of UC segmented by sex and age in these seven markets. The diagnosed incident cases are further segmented by stage at diagnosis and severity grading. The diagnosed prevalent cases are further segmented by severity grading. Additionally, autoimmune comorbidities, colectomy due to failure of medical management, and mortality due to complications of UC among the diagnosed prevalent cases of UC are also included in this analysis. Furthermore, the report includes diagnosed incident cases and diagnosed prevalent cases of indeterminate colitis (IC) for both sexes and all ages in the 7MM.
- The UC epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The UC EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global UC market.
- Quantify patient populations in the global UC market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for UC therapeutics in each of the markets covered.
- Identify the percentage of diagnosed incident cases of UC by stage at diagnosis and severity grading.
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.